Stay updated on Olaptesed with Pembrolizumab in Colorectal and Pancreatic Clinical Trial

Sign up to get notified when there's something new on the Olaptesed with Pembrolizumab in Colorectal and Pancreatic Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Olaptesed with Pembrolizumab in Colorectal and Pancreatic Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The footer’s site revision label changes from v3.7.1 to v3.7.2; the page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-19T12:13:39.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The revision label in the footer changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-12T14:19:58.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    30 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden error instead of the study details, indicating access is blocked and a standard error screen is shown.
    Difference
    19%
    Check dated 2026-09-21T22:07:50.000Z thumbnail image
  5. Check
    51 days ago
    Change Detected
    Summary
    The revision label on the page was updated from v3.6.5 to v3.6.6, indicating a minor update to the ClinicalTrials.gov entry. This change does not alter the study data, eligibility criteria, or outcomes.
    Difference
    0.1%
    Check dated 2026-08-31T17:44:10.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    A new line '2016 ( U.S. NIH Grant/Contract )' was added to the study's identifiers, indicating NIH funding for the trial. This updates the funding attribution without changing the study design or eligibility details.
    Difference
    0.1%
    Check dated 2026-08-24T19:35:03.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    The page revision updated from v3.6.4 to v3.6.5, indicating a minor update to the page’s version or metadata without altering study content.
    Difference
    0.1%
    Check dated 2026-08-10T12:59:55.000Z thumbnail image

Stay in the know with updates to Olaptesed with Pembrolizumab in Colorectal and Pancreatic Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Olaptesed with Pembrolizumab in Colorectal and Pancreatic Clinical Trial page.